Pharmacological characterization of ICa in cones of WT and G369i KI mice and ground squirrel.
a,b, Analysis of mouse cones. Left, representative traces for ICa evoked by voltage ramps in cones of WT or G369i KI mice before (baseline) and after exposure to 1 μM of isradipine (ISR, a, WT, n = 4; G369i KI, n = 5) or 5 μM ML 218 (b, WT, n = 5; G369i KI, n = 5). Right, ICa amplitudes before (-) and during (+) perfusion of the blocker on the same cells. Each point represents a different cell. *, p < 0.05 by paired t-test. c,d, Analysis of ground squirrel cones. Representative traces corresponding to baseline-corrected ICa evoked by voltage ramps (c,d, left) and corresponding G-V plot (c, right) before and during application of ML 218 (c) or ISR alone or ISR+ML218 (d). In d, ICa amplitudes are plotted before (-) and after (+) block for cones in the superior (sup.; n = 7 cones), middle (mid.; n = 5 cones), and inferior (inf.; n = 5 cones) thirds of the retina. The ICa blocked by ISR alone was measured at the peak of the control I-V curve between -40 and -20 mV. The ICa amplitude blocked by adding ML218 was measured as the average current between -50 and -45 mV before ML218 addition relative to zero current following the addition of ML218. The changes produced by ML218 were small but nonetheless significant (sup., n = 7, ISR: p < 0.0001, ML218: p = 0.0047; mid., n = 5, ISR: p < 0.0001, ML218: p = 0.0001; inf., n =5, ISR: p = 0.0019, ML218: p = 0.0460; two-tailed t test).